HALL FREDERICK L has a total of 12 patent applications. Its first patent ever was published in 1949. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are KATHOLIEKE UNIVERSITEIT LEUVEN K U LEUVEN R&D, RAVEN BIOTECHNOLOGIES INC and CENTELION.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Australia | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Medical technology | |
#5 | Measurement | |
#6 | Textiles and paper | |
#7 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Climate change adaptation technologies | |
#6 | Object sterilising | |
#7 | Animal care | |
#8 | Knitting | |
#9 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Hall Frederick L | 12 |
#2 | Gordon Erlinda M | 8 |
#3 | Nimni Marcel E | 3 |
#4 | Reed Rebecca A | 2 |
#5 | Tuan Tai-Lan | 2 |
#6 | Cheung David T | 2 |
#7 | Wu Lintao | 2 |
#8 | Levy John P | 2 |
#9 | Wu Lingtao | 1 |
#10 | Beart Robert W | 1 |
Publication | Filing date | Title |
---|---|---|
US2009123428A1 | Pathotropic targeted gene delivery system for cancer and other disorders | |
US2007178066A1 | Pathotropic targeted gene delivery system for cancer and other disorders | |
US2006292121A1 | Retroviral vectors including modified envelope escort protein | |
AU7714898A | Bone morphogenetic proteins and their use in bone growth | |
AU6152996A | Tgf-beta fusion proteins and their use in wound healing | |
US2546444A | Stocking |